New shot aims to keep severe asthma in check for years
NCT ID NCT06441812
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tests a new medicine called SHR-1703, given as multiple shots under the skin, to see if it is safe and helps control eosinophilic asthma over the long term. About 200 adults with asthma that is not well controlled by standard inhalers will take part. Researchers will track side effects, lung function, and asthma flare-ups for up to two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ASTHMA PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
Contact
Conditions
Explore the condition pages connected to this study.